91 related articles for article (PubMed ID: 2431109)
1. Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue.
Memo M; Missale C; Carruba MO; Spano PF
J Neural Transm Suppl; 1986; 22():19-32. PubMed ID: 2431109
[TBL] [Abstract][Full Text] [Related]
2. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
Clark D; White FJ
Synapse; 1987; 1(4):347-88. PubMed ID: 2971273
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
4. Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract.
Arrighi N; Bodei S; Zani D; Simeone C; Fiorentini C; Missale C; Milanese G; Dellabella M; Muzzonigro G; Cunico SC; Spano P; Sigala S
Neurourol Urodyn; 2009; 28(4):343-8. PubMed ID: 18973141
[TBL] [Abstract][Full Text] [Related]
5. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
[TBL] [Abstract][Full Text] [Related]
6. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
7. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.
Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R
Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092
[TBL] [Abstract][Full Text] [Related]
8. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
[TBL] [Abstract][Full Text] [Related]
9. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
[TBL] [Abstract][Full Text] [Related]
10. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.
Spano PF; Govoni S; Trabucchi M
Adv Biochem Psychopharmacol; 1978; 19():155-65. PubMed ID: 358777
[No Abstract] [Full Text] [Related]
11. On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. With particular reference to dopaminergic mechanisms in the central nervous system.
Hjorth S
Acta Physiol Scand Suppl; 1983; 517():1-52. PubMed ID: 6138921
[TBL] [Abstract][Full Text] [Related]
12. Central dopamine receptors.
Flückiger E; Vigouret JM
Postgrad Med J; 1981; 57 Suppl 1():55-61. PubMed ID: 6117849
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
Sesack SR; Bunney BS
J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
[TBL] [Abstract][Full Text] [Related]
14. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of rat retinal dopamine receptors.
Qu ZX; Fertel R; Neff NH; Hadjiconstantinou M
J Pharmacol Exp Ther; 1989 Feb; 248(2):621-5. PubMed ID: 2493095
[TBL] [Abstract][Full Text] [Related]
16. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
Byrnes EM; Bruno JP
Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
[TBL] [Abstract][Full Text] [Related]
17. Dopamine: receptors and clinical applications.
Goldberg LI
Clin Physiol Biochem; 1985; 3(2-3):120-6. PubMed ID: 3159532
[TBL] [Abstract][Full Text] [Related]
18. Depolarisation-evoked release of dopamine and histamine from brain tissue and studies on presynaptic dopamine-histamine interaction.
Nowak JZ
Pol J Pharmacol Pharm; 1985; 37(3):359-81. PubMed ID: 2866503
[TBL] [Abstract][Full Text] [Related]
19. [Biochemistry and pharmacology of benzamides].
Boyer P
Sem Hop; 1983 Mar; 59(12):832-5. PubMed ID: 6306780
[TBL] [Abstract][Full Text] [Related]
20. Hydergine: interaction with the neurotransmitter systems in the central nervous system.
Markstein R
J Pharmacol; 1985; 16 Suppl 3():1-17. PubMed ID: 2869188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
